The lives of twelve families have been permanently impacted by Lexapro, an antidepressant drug. These 12 families took their cases to court by filing individual Lexapro birth defects lawsuits targeting…
Read More
Though medical devices are developed to improve lives, such is not always the case when discussing transvaginal mesh products. Used to treat stress urinary incontinence (SUI) and pelvic organ prolapse…
Read More
The federal judge who is overseeing the pretrial proceedings in the 7 transvaginal mesh multidistrict litigations (MDLs) urged the defendants in each of the MDLs to settle the tens of…
Read More
Health Canada, the Canadian equivalent of the U.S. Food and Drug Administration (FDA), issued an announcement in early May 2014 with new information on transvaginal mesh. Their announcement pertained specifically…
Read More
In the Boston Scientific transvaginal mesh multidistrict litigation (MDL) taking place in a federal court in West Virginia, the transvaginal mesh manufacturer submitted a request to try cases individually versus…
Read More
Janssen Pharmaceuticals, the arm of Johnson & Johnson behind the anti-seizure drug Topamax, is the target of over 100 lawsuits in the Philadelphia Court of Common Pleas. The pharmaceutical company…
Read More
Sales are down for testosterone replacement therapy drugs, such as the two most popular testosterone gels, Androgel and Axiron. After a huge spike in 2013 in prescriptions and sales, 2014…
Read More
The news has been overrun of late by research connecting testosterone replacement therapy with poor cardiovascular health. Though testosterone gel’s effects on heart health continue to be a major concern,…
Read More
The promises of improved well being made in advertisements for testosterone gel have attracted large numbers of men. However, these promises fall short, and obscure a serious testosterone gel side…
Read More
The New England Journal of Medicine (NEJM) recently conducted a community poll on testosterone gel safety that concluded on December 2, 2014. The purpose of the poll was to get…
Read More